DE60036536T2 - Verfahren zur diagnose von endometriose - Google Patents

Verfahren zur diagnose von endometriose Download PDF

Info

Publication number
DE60036536T2
DE60036536T2 DE60036536T DE60036536T DE60036536T2 DE 60036536 T2 DE60036536 T2 DE 60036536T2 DE 60036536 T DE60036536 T DE 60036536T DE 60036536 T DE60036536 T DE 60036536T DE 60036536 T2 DE60036536 T2 DE 60036536T2
Authority
DE
Germany
Prior art keywords
cd45ro
cd45ra
hladr
endometriosis
markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60036536T
Other languages
German (de)
English (en)
Other versions
DE60036536D1 (de
Inventor
Danièle Montreal GAGNE
Diane Pointe Calumet GOSSELIN
Patrice Sainte Dorothee/Laval HUGO
Pierre Laval MIRON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Medical Solutions Diagnostics Inc USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Medical Solutions Diagnostics Inc USA filed Critical Siemens Medical Solutions Diagnostics Inc USA
Publication of DE60036536D1 publication Critical patent/DE60036536D1/de
Application granted granted Critical
Publication of DE60036536T2 publication Critical patent/DE60036536T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Devices That Are Associated With Refrigeration Equipment (AREA)
  • Measurement Of Mechanical Vibrations Or Ultrasonic Waves (AREA)
DE60036536T 1999-01-25 2000-01-24 Verfahren zur diagnose von endometriose Expired - Lifetime DE60036536T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11703199P 1999-01-25 1999-01-25
US117031P 1999-01-25
PCT/CA2000/000060 WO2000043789A1 (en) 1999-01-25 2000-01-24 Method and diagnostic kit for diagnosis of endometriosis

Publications (2)

Publication Number Publication Date
DE60036536D1 DE60036536D1 (de) 2007-11-08
DE60036536T2 true DE60036536T2 (de) 2008-06-19

Family

ID=22370639

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60036536T Expired - Lifetime DE60036536T2 (de) 1999-01-25 2000-01-24 Verfahren zur diagnose von endometriose

Country Status (10)

Country Link
EP (1) EP1147421B1 (https=)
JP (1) JP2002535658A (https=)
AT (1) ATE374370T1 (https=)
AU (1) AU2088800A (https=)
BR (1) BR0007702A (https=)
CA (1) CA2359200A1 (https=)
DE (1) DE60036536T2 (https=)
ES (1) ES2292424T3 (https=)
NZ (1) NZ513692A (https=)
WO (1) WO2000043789A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2475298A1 (en) * 2002-02-13 2003-08-21 Kamran Shazand Cd16b as a marker for the diagnosis of endometriosis
US20050100967A1 (en) * 2003-07-11 2005-05-12 Science & Technology Corporation @ Unm Detection of endometrial pathology
US20060008876A1 (en) 2004-07-07 2006-01-12 Shami A S E ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
EP1931993A2 (en) * 2005-09-14 2008-06-18 Medizinische Universität Wien Means and methods for diagnosing endometriosis
WO2017039751A1 (en) 2015-08-28 2017-03-09 Bioincept, Llc Mutant peptides and methods of treating subjects using the same
AU2015343202A1 (en) * 2014-11-03 2017-05-25 Bioincept, Llc PIF binding as a marker for immune dysregulation
EP3341006A4 (en) 2015-08-28 2019-03-13 BioIncept LLC COMPOSITIONS AND METHODS FOR TREATING NERVE DAMAGE
WO2020218465A1 (ja) * 2019-04-26 2020-10-29 中外製薬株式会社 子宮内膜症の診断方法、病態モニタリング方法及びキット

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
US5618680A (en) * 1994-12-28 1997-04-08 Institut De Medecine De La Reproduction De Montreal Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis
CA2265470A1 (en) * 1996-09-06 1998-03-12 Osteometer Biotech A/S Biochemical markers of the human endometrium

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose

Also Published As

Publication number Publication date
EP1147421A1 (en) 2001-10-24
DE60036536D1 (de) 2007-11-08
WO2000043789A1 (en) 2000-07-27
CA2359200A1 (en) 2000-07-27
BR0007702A (pt) 2002-09-10
ES2292424T3 (es) 2008-03-16
JP2002535658A (ja) 2002-10-22
ATE374370T1 (de) 2007-10-15
AU2088800A (en) 2000-08-07
NZ513692A (en) 2001-09-28
EP1147421B1 (en) 2007-09-26

Similar Documents

Publication Publication Date Title
DE69433504T2 (de) ALPHAvBETA3 INTEGRIN ALS INDIKATOR FÜR ENDOMETRIOSE
Kolanska et al. Proportion of cytotoxic peripheral blood natural killer cells and T-cell large granular lymphocytes in recurrent miscarriage and repeated implantation failure: case–control study and meta-analysis
DE69130893T2 (de) Therapeutische und diagnostische verfahren unter verwendung vollständiger leukozytenoberflächen antigene
Gagné et al. Development of a nonsurgical diagnostic tool for endometriosis based on the detection of endometrial leukocyte subsets and serum CA-125 levels
Florian et al. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes
Garfield et al. Structural and functional comparison of mast cells in the pregnant versus nonpregnant human uterus
Kunnen et al. The effect of Porphyromonas gingivalis lipopolysaccharide on pregnancy in the rat
Perez et al. Meibomian gland dysfunction: a route of ocular graft-versus-host disease progression that drives a vicious cycle of ocular surface inflammatory damage
DE60036536T2 (de) Verfahren zur diagnose von endometriose
US6743595B1 (en) Method and diagnostic kit for diagnosis of endometriosis
Kuon et al. Pre-pregnancy levels of peripheral natural killer cells as markers for immunomodulatory treatment in patients with recurrent miscarriage
Jacques et al. Necrotizing funisitis: a study of 45 cases
Vallejo-Timarán et al. Pre-and post-partum concentrations of interleukin 1α, interleukin 8, and α1-acid glycoprotein in vaginal fornix and endometrium of dairy cows with clinical cervicitis
Robak et al. Circulating TCR γδ cells in the patients with systemic lupus erythematosus
WO2004003548A1 (de) Verfahren zur eigenschaftsbestimmung und/oder klassifikation von zirkulierenden macrophagen sowie analyseanordnung zur durchführung des verfahrens
US20030219835A1 (en) CD16b as a marker for the diagnosis of endometriosis
Nanni-Costa et al. Flow cytometry evaluation of urinary sediment in renal transplantation
DE69610496T2 (de) Verfahren zur vorhersage der therapeutischen antwort eines medikamentes auf einen malignen tumoren
EP1179179B1 (de) Verwendung eines antikörpers zur detektion von basophilen und/oder mastzellen
DE69912453T2 (de) Verfahren und materialien zur diagnose instabiler angina
Blackwell et al. Unexplained fetal death is associated with changes in the adaptive limb of the maternal immune response consistent with prior antigenic exposure
CN113832222A (zh) 生物标志物在制备用于诊断流产的试剂盒中的用途
Sebire et al. Trophoblast proliferation is increased in chorionic villi from pregnancies with fetal trisomy 18
Parveen et al. A COMPARATIVE STUDY OF CD 56+ NK (NATURAL KILLER) CELLS IN ENDOMETRIAL TISSUE OF NORMAL AND INFERTILE PATIENTS.
Saba et al. Prevalence of Disorder of Villous Maturation and the Pattern of CD15 Immunohistochemical Expression in Placentas with Late Intrauterine Fetal Death

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS INC. (N.D.GES.D, US